> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Clears ACell MicroMatric Wound Cover
- URL: https://www.fdaweb.com/fda-clears-acell-micromatric-wound-cover/
- Published: 2016-03-24T12:00:00.000Z
- Updated: 2026-09-14T20:50:51.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5135186

> FDA has cleared an ACell, Inc. 510(k) for its MicroMatrix device and its concurrent use with Cytal Wound Matrix or Cytal Burn Matrix devices. The micronized particulate form of ACell’s patented Urinary Bladder Matrix technology provides coverage of the wound bed, especially in irregular wounds. It provides a “robust scaffold for cell infiltration and host tissue deposition,” according to the company. The clearance also covers a modification to the device’s Instructions for Use to include the option for device hydration in sterile saline prior to application, in order to facilitate ease of use and adherence to the wound bed, it says.